NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1%
Tue, 13 Aug

NATCO PHARMA has announced its results for the quarter ended June 2019. Here is a detailed performance review of the same:

NATCO PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-18*
3
Mar-19*
3
Jun-19*
QoQ ChangeYoY Change
Net SalesRs m5,3864,5574,9238.0%-8.6%
Other incomeRs m359310210-32.3%-41.5%
TurnoverRs m5,7454,8675,1335.5%-10.7%
ExpensesRs m3,2103,0743,010-2.1%-6.2%
Gross profitRs m2,1761,4831,91329.0%-12.1%
DepreciationRs m1842172201.4%19.6%
InterestRs m28526525.0%132.1%
Profit before taxRs m2,3231,5241,83820.6%-20.9%
TaxRs m51232041028.1%-19.9%
Profit after taxRs m1,8111,2041,42818.6%-21.1%
Gross profit margin%40.432.538.9
Effective tax rate%22.021.022.3
Net profit margin%31.524.727.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 8.6% on a year-on-year (YoY) basis. The expenses were down by 6.2% YoY during the same period.
  • The company's operating profit declined by 12.1% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 38.9% in 1QFY20 as against 40.4% in 1QFY19.
  • Depreciation charges increased by 19.6% and finance costs increased by 132.1% YoY, respectively.
  • Other income declined by 41.5% YoY during the quarter.
  • Net profit for the quarter declined by 21.1% YoY. Net profit margins during the quarter declined from 31.5% in 1QFY19 to 27.8% in 1QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 8.0% on a quarter-on-quarter (QoQ) basis. The expenses were down by 2.1% QoQ during the same period.
  • The company's operating profit increased by 29.0% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 38.9% in 1QFY20 as against 32.5% in 4QFY19.
  • Net profit for the quarter increased by 18.6% QoQ, while net profit margins increased from 24.7% in 4QFY19 to 27.8% in 1QFY20.

To see how NATCO PHARMA has performed over the last eight quarters,please visit here.

NATCO PHARMA Share Price Performance

Over the last one year,NATCO PHARMA share price has moved down from Rs 768.0 to Rs 546.4, registering a Loss of Rs 221.6 or around 28.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 12,722.2 (up 0.2%). Over the last one year it has moved down from 14,332.1 to 12,722.2, a gain of 1,610 points (down 11.2%).

Overall, the S&P BSE SENSEX is down 1.3% over the year.

Current Valuations

At the current price of Rs 546.4, the price to earnings (P/E) ratio of NATCO PHARMA stands at 15.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.0 times.

Equitymaster requests your view! Post a comment on "NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1%". Click here!

  

Related Views on News

NATCO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 34.5% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 34.5% YoY). Sales on the other hand came in at Rs 5 bn (down 13.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

More Views on News

Most Popular

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Jan 22, 2021 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA 8-QTR ANALYSIS

COMPARE NATCO PHARMA WITH

MARKET STATS